Cargando…

Association of SDF-1 Gene Polymorphism with Increased Risk of Acute Myeloid Leukemia Patients

BACKGROUND: Acute myeloid leukemia (AML) is a heterogenous group of disorders that emerge from the malignant transformation of hematopoietic stem cells. Chemokine stromal cell-derived factor 1(SDF-1) and its receptor CXC receptor 4 (CXCR4) has an essential role in dissemination of blast cells. Study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aladle, Doaa Abd Allah M, Ghannam, Mayada A, El-Ashwah, Shaimaa, Ghobrial, F E I, Mortada, Metwaly Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325146/ https://www.ncbi.nlm.nih.gov/pubmed/33906294 http://dx.doi.org/10.31557/APJCP.2021.22.4.1035

Ejemplares similares

Prognostic Impact of IL17 A Gene Polymorphismson Egyptian Patients with Multiple Myeloma
por: Mortada, Metwaly Ibrahim, et al.
Publicado: (2023)

Isolated Myeloperoxidase Immunohistochemical Expression in Bone Marrow Biopsy Depicts Clinical Outcomes in Adults with Typical B-Acute Lymphoblastic Leukemia
por: Fawzy, Maha Mohamed, et al.
Publicado: (2021)

AML-174 Dilemma of Treating Acute Myeloid Leukemia Patient After Kidney Transplant in the COVID-19 Era
por: El-Ashwah, Shaimaa, et al.
Publicado: (2022)

TERT Genotype Polymorphism: A Glance of Change Egyptian MDS Outcomes
por: El Menshawy, Nadia, et al.
Publicado: (2021)

The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review
por: Mansour, Reham Osama, et al.
Publicado: (2023)

Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia
por: Aref, Salah, et al.
Publicado: (2022)

Prognostic Impact of Nucleophosmin 1 (NPM1) Gene Mutations in Egyptian Acute Myeloid Leukemia Patients
por: Zidan, Magda, et al.
Publicado: (2013)

Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity
por: El Menshawy, Nadia, et al.
Publicado: (2020)

Hypercalcemia With Disseminated Osteolytic Lesions: A Rare Presentation of Adulthood Acute Lymphoblastic Leukemia
por: El-Ashwah, Shaimaa, et al.
Publicado: (2018)

Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients
por: Aref, Salah, et al.
Publicado: (2020)

Prognostic Value of Brain and Acute Leukemia Cytoplasmic Gene Expression in Egyptian Children with Acute Myeloid Leukemia
por: Hagag, Adel A., et al.
Publicado: (2015)

Cimigenol depresses acute myeloid leukemia cells protected by breaking bone marrow stromal cells via CXCR4/SDF‑1α
por: Ma, Bangyun, et al.
Publicado: (2022)

Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
por: Alarcón-Payer, Carolina, et al.
Publicado: (2022)

Fas-670A>G polymorphism is not associated with an increased risk of acute myeloid leukemia development
por: HUANG, YING, et al.
Publicado: (2016)

Prognostic Significance of the Lymphoblastic Leukemia-Derived Sequence 1 (LYL1) GeneExpression in Egyptian Patients with AcuteMyeloid Leukemia
por: El-Menshawy, Nadia, et al.
Publicado: (2014)

DNA Repair Genes Polymorphisms: Impact on Acute Myeloid Leukemia Patients Outcome
por: Aref, Salah, et al.
Publicado: (2022)

Predictive Value of Kozak Gene Polymorphism for Thrombosis in Patients with Philadelphia-Negative MPNs
por: El-Ghonemy, Mohamed Sabry, et al.
Publicado: (2021)

Role of Granulocyte-Macrophage Colony-Stimulating Factor in Acute Myeloid Leukemia/Myelodysplastic Syndromes
por: Kassem, Neemat M., et al.
Publicado: (2017)

Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
por: Wu, Yuyan, et al.
Publicado: (2023)

SDF1-3′A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis
por: Zhang, Xiaowen, et al.
Publicado: (2017)

Venetoclax-containing regimens in acute myeloid leukemia
por: Aldoss, Ibrahim, et al.
Publicado: (2021)

Short Dysfunctional Telomere Is Highly Predictive of Dismal Outcome in MDS but Not in AML Patients
por: Menshawy, Nadia El, et al.
Publicado: (2020)

Systemic vascular resistance and fluid status in patients with decompensated liver cirrhosis with or without functional renal failure in Egypt
por: Barakat, Ashraf Abd El-Khalik, et al.
Publicado: (2015)

Interleukin-10 (1082G/A) Polymorphism is Associated with Susceptibility of Acute Myeloid Leukemia Patients in Sudanese Population
por: Mohamed Sharif, Omnia, et al.
Publicado: (2019)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
por: Goswami, Meghali, et al.
Publicado: (2022)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2015)

SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease
por: Rath, Dominik, et al.
Publicado: (2016)

IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia
por: Wróbel, Tomasz, et al.
Publicado: (2014)

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)

PB1750: PHILADELPHIA CHROMOSOME POSITIVE ALL EGYPTIAN PATIENTS: CLINICAL PROFILE & OUTCOME. A SINGLE CENTER EXPERIENCE.
por: Shaaban, Yasmine, et al.
Publicado: (2023)

Update on Optimal Management of Acute Myeloid Leukemia
por: El Rassi, Fuad, et al.
Publicado: (2013)

CD34+/CD38- Stem Cell Burden Could Predict Chronic Myeloid Leukemia Patients’ Outcome
por: Fathy El-Metwaly, Noura, et al.
Publicado: (2021)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs
por: Panina, Svetlana B., et al.
Publicado: (2019)

Acute Myeloid Leukemia: Is That All There Is?
por: Saif, Aneeqa, et al.
Publicado: (2018)

Classification of acute myeloid leukemia
por: Hwang, Sang Mee
Publicado: (2020)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uc3tn3sjsekpdgo9thn1c080kc